Puneet Varma (Editor)

Hypoprothrombinemia

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Specialty
  
hematology

ICD-9-CM
  
286.3, 776.3

MeSH
  
D007020

ICD-10
  
D68.2

eMedicine
  
ped/1133

Hypoprothrombinemia is a blood disorder in which a deficiency of prothrombin (Factor II) results in impaired blood clotting, leading to an increased physiological risk for bleeding, especially in the gastrointestinal system, cranial vault, and superficial integumentary system.

Contents

Causes

Hypoprothrombinemia can be the result of a genetic defect, may be acquired as the result of another disease process, or may be an adverse effect of medication. For example, 5-10% of patients with systemic lupus erythematosus exhibit acquired hypoprothrombinemia due to the presence of autoantibodies which bind to prothrombin and remove it from the bloodstream (lupus anticoagulant-hypoprothrombinaemia syndrome).

It may also be a rare adverse effect to Rocephin.

Treatment

Hypoprothrombinemia can be treated with periodic infusions of purified prothrombin complexes.

  1. A known treatment for hypoprothrombinemia is menadoxime.
  2. Menatetrenone was also listed as a Antihaemorrhagic vitamin.
  3. 4-Amino-2-methyl-1-naphthol (Vitamin K5) is another treatment for hypoprothrombinemia.

References

Hypoprothrombinemia Wikipedia